Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$26.33 – $39.20
24% from low
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.10T | $3.29T | $3.20T | $3.57T | $4.03T | $4.26T | $4.58T | $4.53T |
| Cost of revenue | $659.69B | $1.09T | $994.31B | $1.11T | $1.24T | $1.43T | $1.58T | $2.22T |
| Gross profit | $1.44T | $2.20T | $2.20T | $2.46T | $2.78T | $2.83T | $3.00T | $2.32T |
| Gross margin | 68.5% | 66.9% | 68.9% | 69.0% | 69.1% | 66.4% | 65.5% | 51.1% |
| R&D | $368.30B | $492.38B | $455.83B | $526.09B | $633.33B | $729.92B | $730.23B | $680.18B |
| Operating income | $204.97B | $100.41B | $509.27B | $460.84B | $490.50B | $214.07B | $342.59B | $543.85B |
| EBITDA | $464.22B | $671.90B | $1.06T | $1.01T | $1.16T | $900.33B | $1.07T | $1.27T |
| Net income | $109.13B | $44.24B | $376.00B | $230.06B | $317.02B | $144.07B | $107.93B | $192.97B |
| Net margin | 5.2% | 1.3% | 11.8% | 6.4% | 7.9% | 3.4% | 2.4% | 4.3% |
| EPS (diluted) | 112.86 | 28.25 | 238.96 | 145.87 | 201.94 | 91.16 | 67.23 | 119.84 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2027 | $4.66T | $118.10 | $110.31–$125.07 | 3 |
| 2028 | $4.73T | $194.74 | $181.91–$206.24 | 3 |
| 2029 | $4.82T | $239.64 | $223.85–$253.79 | 4 |
| 2030 | $5.09T | $252.33 | $235.70–$267.24 | 2 |
Forward consensus · source: Financial Modeling Prep
TAKEDA PHARM CO LTD ORD
No one on the platform currently holds TKPHF.
No tracked institution reports a position in TKPHF as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2027-03-31 | $102.0000 | |
| 2026-09-30 | $102.0000 | |
| 2026-03-31 | $100.0000 | 2026-06-25 |
| 2025-09-30 | $100.0000 | 2025-12-01 |
| 2025-03-31 | $98.0000 | 2025-06-26 |
| 2024-09-30 | $98.0000 | 2024-12-02 |
| 2024-03-28 | $94.0000 | 2024-06-27 |
| 2023-09-29 | $94.0000 | 2023-12-01 |
No one on the platform has traded TKPHF yet.
| -1.74% |
| $39.9B |
| — |
| HOCPFHOYA Corporation | $154.58 | -8.26% | $51.7B | — |
| IPSEYIpsen S.A. | $46.51 | +0.02% | $61.5B | — |
Source: Financial Modeling Prep · peers by sector/industry
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
Trading at 0.4× earnings vs its 0.2× historical median P/E.
Fair value ≈ $15.79 · price $29.43 today
Fair-value line = the stock's median historical P/E × earnings. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.